Your browser doesn't support javascript.
loading
The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination.
Laitman, Benjamin M; Asp, Linnéa; Mariani, John N; Zhang, Jingya; Liu, Jia; Sawai, Setsu; Chapouly, Candice; Horng, Sam; Kramer, Elisabeth G; Mitiku, Nesanet; Loo, Hannah; Burlant, Natalie; Pedre, Xiomara; Hara, Yuko; Nudelman, German; Zaslavsky, Elena; Lee, Young-Min; Braun, David A; Lu, Q Richard; Narla, Goutham; Raine, Cedric S; Friedman, Scott L; Casaccia, Patrizia; John, Gareth R.
Afiliação
  • Laitman BM; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Asp L; Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Mariani JN; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Zhang J; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Liu J; Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Sawai S; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Chapouly C; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Horng S; Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Kramer EG; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Mitiku N; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Loo H; Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Burlant N; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Pedre X; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Hara Y; Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Nudelman G; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Zaslavsky E; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Lee YM; Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Braun DA; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Lu QR; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Narla G; Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Raine CS; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Friedman SL; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Casaccia P; Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • John GR; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
PLoS Biol ; 14(5): e1002467, 2016 05.
Article em En | MEDLINE | ID: mdl-27213272
Growth factors of the gp130 family promote oligodendrocyte differentiation, and viability, and myelination, but their mechanisms of action are incompletely understood. Here, we show that these effects are coordinated, in part, by the transcriptional activator Krüppel-like factor-6 (Klf6). Klf6 is rapidly induced in oligodendrocyte progenitors (OLP) by gp130 factors, and promotes differentiation. Conversely, in mice with lineage-selective Klf6 inactivation, OLP undergo maturation arrest followed by apoptosis, and CNS myelination fails. Overlapping transcriptional and chromatin occupancy analyses place Klf6 at the nexus of a novel gp130-Klf-importin axis, which promotes differentiation and viability in part via control of nuclear trafficking. Klf6 acts as a gp130-sensitive transactivator of the nuclear import factor importin-α5 (Impα5), and interfering with this mechanism interrupts step-wise differentiation. Underscoring the significance of this axis in vivo, mice with conditional inactivation of gp130 signaling display defective Klf6 and Impα5 expression, OLP maturation arrest and apoptosis, and failure of CNS myelination.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema Nervoso Central / Proteínas Proto-Oncogênicas / Fatores de Transcrição Kruppel-Like Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema Nervoso Central / Proteínas Proto-Oncogênicas / Fatores de Transcrição Kruppel-Like Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article